Skip to content
Open Data Finder
Open Government Canada

Notice: Prescription Drug List (PDL): Hyoscine butylbromide

Published by Health Canada | Santé Canada

About this dataset

The purpose of this Notice of Amendment is to notify that Health Canada will switch injectable Hyoscine butylbromide to prescription status from ethical status for human use by adding it to the Human Prescription Drug List (PDL). Injectable Hyoscine butylbromide is already listed on the Veterinary Prescription Drug List.

Notice: Prescription Drug List (PDL): Hyoscine butylbromide · Open Data Finder